<table frame="void" width="590" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<thead>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">
<content stylecode="bold">Interacting Drug</content>
</td>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">
<content stylecode="bold">Interaction</content>
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">Multivalent cation-containing products including antacids, metal cations or didanosine</td>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">Absorption of levofloxacin is decreased when the tablet or oral solution formulation is taken within 2 hours of these products. Do not co-administer the intravenous formulation in the same IV line with a multivalent cation, e.g., magnesium (<linkhtml href="#b07b0c11-88f8-4b91-ab61-07cd08d22324">2.4</linkhtml>, <linkhtml href="#ba2d3c3c-c04f-4fee-9df7-11071044e9d8">7.1</linkhtml>)</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">Warfarin</td>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">Effect may be enhanced. Monitor prothrombin time, INR, watch for bleeding (<linkhtml href="#b565c2e9-e556-46f4-bab9-e77bb29afaa2">7.2</linkhtml>)</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">Antidiabetic agents</td>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="middle">Carefully monitor blood glucose (<linkhtml href="#b4929849-9074-402b-a792-d9ee7b2ee1f9">5.11</linkhtml>, <linkhtml href="#b8bbf718-c4f1-4e93-9d18-d355480fa990">7.3</linkhtml>) </td>
</tr>
</tbody>
</table>